Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2017

01-10-2017 | Editorial

Understanding the Differences Between Gastroparesis and Gastroparesis-Like Syndrome: Filling a GaPing Hole?

Authors: Jonathan Gotfried, Ron Schey

Published in: Digestive Diseases and Sciences | Issue 10/2017

Login to get access

Excerpt

The terms gastroparesis (GP) and gastroparesis-like syndrome (GLS) are used to diagnose patients experiencing similar symptoms of nausea, vomiting, and postprandial abdominal pain with GP defined as this symptom complex accompanied by delayed gastric emptying (GE). A current conundrum is why similar symptoms are present in these two groups despite differing gastric motor function. Historically, studies have focused on interstitial cells of Cajal (ICC) networks and collagen fibrosis in the gastric antrum, although their results do not explain the development of delayed gastric emptying (GE) in some patients and not in others. Growing interest in the pylorus stems from attempts to determine whether aberrant pyloric function is the mechanism that delays GE in GP and not in GLS patients, despite both groups experiencing similar symptoms. Previously, authors have suggested that GP and GLS exist along a continuum of the same pathophysiologic process of a complex interplay of inflammation, fibrosis, and neural network changes that alter gastric motility and eventually lead to delayed GE [1]. As such, the contribution of each of these physiologic derangements to the development of symptoms and, in some patients, delayed GE is unknown. A better understanding of the pathophysiologic mechanisms that lead to the unique clinical manifestations of GP and GLS is thus essential to developing novel therapies [2]. …
Literature
1.
go back to reference Harer KN, Pasricha PJ. Chronic unexplained nausea and vomiting or gastric neuromuscular dysfunction (GND)? An update on nomenclature, pathophysiology and treatment, and relationship to gastroparesis. Curr Treat Opt Gastroenterol. 2016;14:410–419.CrossRef Harer KN, Pasricha PJ. Chronic unexplained nausea and vomiting or gastric neuromuscular dysfunction (GND)? An update on nomenclature, pathophysiology and treatment, and relationship to gastroparesis. Curr Treat Opt Gastroenterol. 2016;14:410–419.CrossRef
3.
go back to reference Bashashati M, Moraveji S, Torabi A, et al. Pathological findings of the antral and pyloric smooth muscle in patients with gastroparesis-like syndrome compared to gastroparesis: similarities and differences. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-017-4629-4.PubMed Bashashati M, Moraveji S, Torabi A, et al. Pathological findings of the antral and pyloric smooth muscle in patients with gastroparesis-like syndrome compared to gastroparesis: similarities and differences. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-017-4629-4.PubMed
4.
go back to reference Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg. 2011;15:1513–1519.CrossRefPubMed Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg. 2011;15:1513–1519.CrossRefPubMed
5.
go back to reference Khashab MA, Ngamruengphong S, Carr-Locke D, et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017;85:123–128.CrossRefPubMed Khashab MA, Ngamruengphong S, Carr-Locke D, et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017;85:123–128.CrossRefPubMed
6.
go back to reference Reddymasu SC, Singh S, Sankula R, Lavenbarg TA, Olyaee M, McCallum RW. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis. Am J Med Sci. 2009;337:161–164.CrossRefPubMed Reddymasu SC, Singh S, Sankula R, Lavenbarg TA, Olyaee M, McCallum RW. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis. Am J Med Sci. 2009;337:161–164.CrossRefPubMed
7.
go back to reference Wang XY, Lammers WJ, Bercik P, Huizinga JD. Lack of pyloric interstitial cells of cajal explains distinct peristaltic motor patterns in stomach and small intestine. Am J Physiol Gastrointest Liver Physiol. 2005;289:G539–G549.CrossRefPubMed Wang XY, Lammers WJ, Bercik P, Huizinga JD. Lack of pyloric interstitial cells of cajal explains distinct peristaltic motor patterns in stomach and small intestine. Am J Physiol Gastrointest Liver Physiol. 2005;289:G539–G549.CrossRefPubMed
8.
go back to reference Vanderwinden J, Liu H, De Laet M, Vanderhaeghen J. Study of the interstitial cells of cajal in infantile hypertrophic pyloric stenosis. Gastroenterology. 1996;111:279–288.CrossRefPubMed Vanderwinden J, Liu H, De Laet M, Vanderhaeghen J. Study of the interstitial cells of cajal in infantile hypertrophic pyloric stenosis. Gastroenterology. 1996;111:279–288.CrossRefPubMed
9.
go back to reference Moraveji S, Bashashati M, Elhanafi S, et al. Depleted interstitial cells of cajal and fibrosis in the pylorus: novel features of gastroparesis. Neurogastroenterol Motil. 2016;28:1048–1054.CrossRefPubMed Moraveji S, Bashashati M, Elhanafi S, et al. Depleted interstitial cells of cajal and fibrosis in the pylorus: novel features of gastroparesis. Neurogastroenterol Motil. 2016;28:1048–1054.CrossRefPubMed
10.
go back to reference Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140:1575.e8–1585.e8.CrossRef Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140:1575.e8–1585.e8.CrossRef
11.
go back to reference Heckert J, Thomas R, Parkman H. Gastric neuromuscular histology in patients with refractory gastroparesis: relationships to etiology, gastric emptying, and response to gastric electric stimulation. Neurogastroenterol Motil. 2017;29:e13068.CrossRef Heckert J, Thomas R, Parkman H. Gastric neuromuscular histology in patients with refractory gastroparesis: relationships to etiology, gastric emptying, and response to gastric electric stimulation. Neurogastroenterol Motil. 2017;29:e13068.CrossRef
12.
go back to reference Patterson LM, Zheng H, Ward SM, Berthoud H. Immunohistochemical identification of cholecystokinin A receptors on interstitial cells of cajal, smooth muscle, and enteric neurons in rat pylorus. Cell Tissue Res. 2001;305:11–23.CrossRefPubMed Patterson LM, Zheng H, Ward SM, Berthoud H. Immunohistochemical identification of cholecystokinin A receptors on interstitial cells of cajal, smooth muscle, and enteric neurons in rat pylorus. Cell Tissue Res. 2001;305:11–23.CrossRefPubMed
13.
14.
go back to reference Wang X, Huizinga J, Diamond J, Liu L. Loss of intramuscular and submuscular interstitial cells of cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin-induced diabetes. Neurogastroenterol Motil. 2009;21:1095-e92.CrossRefPubMed Wang X, Huizinga J, Diamond J, Liu L. Loss of intramuscular and submuscular interstitial cells of cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin-induced diabetes. Neurogastroenterol Motil. 2009;21:1095-e92.CrossRefPubMed
15.
go back to reference Zhang R, Wang X, Chen D, Huizinga J. Role of interstitial cells of cajal in the generation and modulation of motor activity induced by cholinergic neurotransmission in the stomach. Neurogastroenterol Motil. 2011;23:e356–e371.CrossRefPubMed Zhang R, Wang X, Chen D, Huizinga J. Role of interstitial cells of cajal in the generation and modulation of motor activity induced by cholinergic neurotransmission in the stomach. Neurogastroenterol Motil. 2011;23:e356–e371.CrossRefPubMed
16.
go back to reference Faussone-Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012;16:1573–1581.CrossRefPubMedPubMedCentral Faussone-Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012;16:1573–1581.CrossRefPubMedPubMedCentral
Metadata
Title
Understanding the Differences Between Gastroparesis and Gastroparesis-Like Syndrome: Filling a GaPing Hole?
Authors
Jonathan Gotfried
Ron Schey
Publication date
01-10-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4702-z

Other articles of this Issue 10/2017

Digestive Diseases and Sciences 10/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine